⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

MRK

Merck & Co., Inc.

Healthcare · Drug Manufacturers - General

145.27USD

-1.9700 (-1.34%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on MRK.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 145.27
P/E113.0
Dvd Ind Yld2.3%
P/B8.55
P/S5.4
Curr EV/T12M EBITDA14.0
Mkt Cap (USD)358.4B
Curr EV (USD)405.2B
2)

Per Share Data

EPS T12M1.24
DPS3.36
Bk Val Per Sh16.99
Rev/Sh26.95
Cash/Sh2.89
Curr Shares Out2,467.2M
FCF/Sh6.50
3)

Cash Flow Analysis

P/CF17.9
Curr P/FCF22.3
CF/NI6.3
Dvd P/O261.5%
Cash Gen/Cash Reqd1.6
Csh Dvd Cov2.4
CFO/Sales30.0%
Eff Interest Rate3.9%
4)

Growth Potential

Dil EPS 1Y Gr8.0%
Cap 1Y Gr22.2%
BPS 1Y Gr15.1%
R&D To Sales45.7%
Retention Rate-161.5%
Rev 1Y Gr1.3%
FCF 1Y Gr-31.7%
Assets 1Y Gr16.9%
5)

Profitability

EBITDA28.9B
EBIT—
Operating Margin-0.2%
Pretax Margin8.9%
Net Margin4.8%
ROA2.6%
ROE7.0%
ROC—
Asset Turnover0.54
6)

Structure

Current Ratio1.32
Quick Ratio0.74
Debt/Assets41.5%
Debt/Com Eq128.6%
Net Debt/EBITDA1.63
Tot Debt/Capital56.2%
Gross Margin73.0%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.